---
schema_version: "secwatch.filing_event.v1"
accession: "0001606498-24-000089"
form_type: "8-K"
ticker: "AVNS"
cik: "0001606498"
company_name: "AVANOS MEDICAL, INC."
filed_at: "2024-11-04T23:59:59+00:00"
generated_at: "2026-05-30T06:06:13.003556+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Avanos Medical authorizes new $25M share repurchase program

## Summary
- Board approved up to $25.0 million in common stock repurchases over one year.
- Repurchases to be made at management's discretion on open market or via private transactions.
- Program will not commence until at least one full trading day after release of any material non-public info.
- Company is not obligated to repurchase any specific amount; program may be suspended or discontinued.

## SEC filing metadata
- accession: 0001606498-24-000089
- form_type: 8-K
- ticker: AVNS
- cik: 0001606498
- company_name: AVANOS MEDICAL, INC.
- filed_at: 2024-11-04T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1606498/000160649824000089/0001606498-24-000089-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1606498/000160649824000089/avns-20241101.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001606498-24-000089
- JSON: https://secwatch.observer/filing/0001606498-24-000089.json
- Plain text: https://secwatch.observer/filing/0001606498-24-000089.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.